Drivers of and barriers to routine adult vaccination: A systematic literature review.

Amanda L Eiden, Jane Barratt, Mawuli K Nyaku
Author Information
  1. Amanda L Eiden: Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA. ORCID
  2. Jane Barratt: International Federation on Ageing, Toronto, Ontario, Canada.
  3. Mawuli K Nyaku: Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA.

Abstract

We performed a systematic literature review in PubMed and Embase (2016-2021) to investigate the drivers of and barriers to routine vaccination in adults aged 50 and older globally. A thematic assessment identified three categories across 61 publications: sociodemographic, health-related, and attitudinal. The most common sociodemographic determinants (factors identified in studies; n���=���47) associated with vaccination uptake were economic status, age, education, and household composition, which had mixed effects on vaccine uptake. For health-related determinants (n���=���27), individuals with comorbidities and health care consumption were the most common factors, both increased vaccine uptake. The most common attitudinal factors (n���=���42) were self-efficacy, provider or other's recommendations, and vaccine-preventable disease awareness; across studies, all attitude factors had a positive effect, unlike the sociodemographic and health status categories. Findings suggest that patient and provider awareness and education campaigns are effective ways to increase uptake of routine vaccinations in older adults.

Keywords

References

  1. PeerJ. 2018 Jul 13;6:e5171 [PMID: 30013841]
  2. BMJ Open. 2016 Dec 28;6(12):e012618 [PMID: 28031209]
  3. BMC Public Health. 2016 Feb 04;16:121 [PMID: 26846202]
  4. Vaccine. 2021 Mar 12;39(11):1556-1564 [PMID: 33618947]
  5. Hum Vaccin Immunother. 2018 Jun 3;14(6):1342-1350 [PMID: 29451834]
  6. Health Promot Int. 2020 Dec 1;35(6):1427-1440 [PMID: 32105311]
  7. Vaccine. 2017 Apr 25;35(18):2396-2403 [PMID: 28343782]
  8. Cad Saude Publica. 2020;36 Suppl 2:e00237419 [PMID: 32876100]
  9. Vaccine. 2017 Apr 25;35(18):2372-2378 [PMID: 28363324]
  10. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E51-E64 [PMID: 31016268]
  11. PLoS One. 2016 Nov 10;11(11):e0166517 [PMID: 27832186]
  12. PLoS One. 2016 Jun 23;11(6):e0158075 [PMID: 27336627]
  13. J Infect Dis. 2020 Jan 2;221(2):183-190 [PMID: 31678990]
  14. Vaccine. 2016 Jul 12;34(32):3657-62 [PMID: 27255466]
  15. PLoS One. 2016 Jan 29;11(1):e0147931 [PMID: 26824383]
  16. MMWR Surveill Summ. 2021 May 14;70(3):1-26 [PMID: 33983910]
  17. Epidemiol Serv Saude. 2016 Oct-Dec;25(4):755-766 [PMID: 27869969]
  18. Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76 [PMID: 23210147]
  19. Vaccine. 2002 Jun 7;20(19-20):2562-78 [PMID: 12057614]
  20. MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1151-4 [PMID: 25503917]
  21. Vaccine. 2017 Dec 18;35(51):7095-7100 [PMID: 29122385]
  22. Int J Environ Res Public Health. 2017 Jun 20;14(6): [PMID: 28632192]
  23. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E38-E44 [PMID: 31016266]
  24. Gerontologist. 2018 Jul 13;58(4):e205-e217 [PMID: 28329831]
  25. Aging Clin Exp Res. 2020 Sep;32(9):1821-1828 [PMID: 31606859]
  26. Vaccine. 2018 Mar 7;36(11):1467-1476 [PMID: 29426662]
  27. J Mark Access Health Policy. 2015 Aug 12;3: [PMID: 27123189]
  28. Vaccine. 2017 May 19;35(22):2882-2891 [PMID: 28449971]
  29. Hum Vaccin Immunother. 2015;11(9):2158-66 [PMID: 26091249]
  30. Vaccine. 2020 Aug 18;38(37):5891-5895 [PMID: 32703748]
  31. Saudi Med J. 2019 Oct;40(10):1013-1018 [PMID: 31588480]
  32. Expert Rev Vaccines. 2019 Nov;18(11):1167-1185 [PMID: 31791159]
  33. Nagoya J Med Sci. 2020 Aug;82(3):469-476 [PMID: 33132431]
  34. J Community Health. 2018 Feb;43(1):201-206 [PMID: 28695426]
  35. Asia Pac J Public Health. 2017 Oct;29(7):560-568 [PMID: 29020801]
  36. Epidemiol Infect. 2017 Jul;145(9):1786-1796 [PMID: 28434418]
  37. Vaccine. 2020 Mar 4;38(11):2503-2511 [PMID: 32046892]
  38. Ann Ig. 2020 May-Jun;32(3):205-222 [PMID: 32266359]
  39. BMJ Open. 2019 Sep 17;9(9):e031802 [PMID: 31530622]
  40. Vaccine. 2020 Jan 16;38(3):470-481 [PMID: 31767469]
  41. Can Pharm J (Ott). 2014 Nov;147(6):359-65 [PMID: 25364353]
  42. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E26-E30 [PMID: 31016264]
  43. Vaccine. 2016 Feb 10;34(7):942-9 [PMID: 26752065]
  44. Vaccine. 2018 Jun 14;36(25):3666-3673 [PMID: 29739721]
  45. PLoS One. 2017 Nov 29;12(11):e0188422 [PMID: 29186159]
  46. Hum Vaccin Immunother. 2018 Feb 1;14(2):430-441 [PMID: 29194019]
  47. BMC Public Health. 2018 Oct 12;18(1):1172 [PMID: 30314498]
  48. Curr Opin Immunol. 2014 Aug;29:38-42 [PMID: 24769424]
  49. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E45-E50 [PMID: 31016267]
  50. Epidemiol Infect. 2017 Mar;145(4):775-786 [PMID: 27927253]
  51. Hum Vaccin Immunother. 2021 Feb 1;17(2):527-536 [PMID: 32614636]
  52. Ann Med. 2019 Mar;51(2):128-140 [PMID: 31025882]
  53. J Nurs Manag. 2018 Mar;26(2):158-166 [PMID: 28857349]
  54. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E65-E70 [PMID: 31016269]
  55. PLoS Med. 2021 Nov 4;18(11):e1003826 [PMID: 34735440]
  56. BMC Fam Pract. 2016 Jul 29;17:98 [PMID: 27473612]
  57. BMJ Open. 2017 Sep 25;7(9):e017459 [PMID: 28951412]
  58. Hum Vaccin Immunother. 2019;15(4):841-849 [PMID: 30676236]
  59. Int J Clin Pharm. 2021 Oct;43(5):1163-1172 [PMID: 34047881]
  60. Ann Fam Med. 2013 Sep-Oct;11(5):429-36 [PMID: 24019274]
  61. BMC Public Health. 2013 Apr 25;13:388 [PMID: 23617788]
  62. Epidemiol Health. 2018;40:e2018034 [PMID: 30056640]
  63. Ann Intern Med. 2018 Oct 2;169(7):467-473 [PMID: 30178033]
  64. Hum Vaccin Immunother. 2018;14(12):2987-2989 [PMID: 30118635]
  65. J Infect Dis. 2019 Apr 8;219(Suppl_1):S97-S106 [PMID: 30715348]
  66. Vaccine. 2022 Feb 7;40(6):945-952 [PMID: 35039193]
  67. BMC Fam Pract. 2018 Sep 5;19(1):153 [PMID: 30185157]
  68. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211014071 [PMID: 34032159]
  69. Hum Vaccin Immunother. 2016 Jul 2;12(7):1891-9 [PMID: 27064311]
  70. Prev Med Rep. 2019 Jul 25;16:100959 [PMID: 31440442]
  71. Open Forum Infect Dis. 2014 May 27;1(1):ofu024 [PMID: 25734097]
  72. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E18-E25 [PMID: 31016263]
  73. Int J Equity Health. 2016 Mar 08;15:45 [PMID: 26956154]
  74. Vaccine. 2016 Nov 11;34(47):5708-5723 [PMID: 27765379]
  75. Psychol Health Med. 2020 Oct;25(9):1083-1093 [PMID: 31958989]
  76. Hum Vaccin Immunother. 2019;15(4):863-872 [PMID: 30633706]
  77. Am J Prev Med. 2017 Sep;53(3):e97-e104 [PMID: 28237636]
  78. Hum Vaccin Immunother. 2020 Sep 1;16(9):2292-2299 [PMID: 32045317]
  79. Euro Surveill. 2018 Apr;23(17): [PMID: 29717693]
  80. Vaccines (Basel). 2020 Nov 09;8(4): [PMID: 33182426]
  81. Infect Dis Health. 2019 Nov;24(4):212-221 [PMID: 31402297]
  82. Hum Vaccin Immunother. 2013 Jul;9(7):1500-11 [PMID: 23732900]
  83. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E31-E37 [PMID: 31016265]
  84. Vaccines (Basel). 2020 Jun 19;8(2): [PMID: 32575497]
  85. Vaccines (Basel). 2021 Nov 24;9(12): [PMID: 34960124]
  86. Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941 [PMID: 29342498]
  87. Colomb Med (Cali). 2016 Mar 30;47(1):25-30 [PMID: 27226661]
  88. Vaccine. 2019 Oct 16;37(44):6665-6672 [PMID: 31542261]
  89. Vaccine. 2016 Apr 19;34(18):2135-40 [PMID: 26917011]
  90. Am J Infect Control. 2015 May 1;43(5):e1-5 [PMID: 25798776]
  91. Vaccine. 2018 Jan 25;36(4):442-452 [PMID: 29287683]
  92. Int J Infect Dis. 2017 Dec;65:122-127 [PMID: 29042178]
  93. Wkly Epidemiol Rec. 2014 Jun 20;89(25):265-87 [PMID: 24983077]
  94. BMJ Open. 2016 Oct 18;6(10):e011539 [PMID: 27797989]
  95. Scand J Public Health. 2018 Mar;46(2):175-181 [PMID: 28701087]
  96. Hum Vaccin Immunother. 2021 May 4;17(5):1403-1411 [PMID: 33270473]
  97. J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E11-E17 [PMID: 31016262]
  98. Adv Ther. 2020 May;37(5):2224-2235 [PMID: 32274750]

MeSH Term

Humans
Middle Aged
Aged
Vaccination
Vaccines
Vaccine-Preventable Diseases
Educational Status
Socioeconomic Factors

Chemicals

Vaccines

Word Cloud

Created with Highcharts 10.0.0sociodemographicfactorsuptakeroutinevaccinationoldercommonhealthsystematicliteraturereviewbarriersadultsidentifiedcategoriesacrosshealth-relatedattitudinaldeterminantsstudiesstatuseducationvaccineproviderawarenessadultperformedPubMedEmbase2016-2021investigatedriversaged50globallythematicassessmentthree61publications:n���=���47associatedeconomicagehouseholdcompositionmixedeffectsn���=���27individualscomorbiditiescareconsumptionincreasedn���=���42self-efficacyother'srecommendationsvaccine-preventablediseaseattitudepositiveeffectunlikeFindingssuggestpatientcampaignseffectivewaysincreasevaccinationsDriversvaccination:Vaccinesimmunizationpubliccoverage

Similar Articles

Cited By